Antibody-based therapies for infectious diseases: renaissance for an abandoned arsenal?

被引：4

作者：

Casadevall, A

Goldman, DL

Feldmesser, M

机构：

[1] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA

[2] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol, Bronx, NY 10461 USA

[3] Yeshiva Univ Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA

来源：

BULLETIN DE L INSTITUT PASTEUR | 1997年 / 95卷 / 04期

关键词：

therapeutics; immunoglobulin; opportunistic infection; HIV; RSV; antibiotic; resistance; septic shock; review;

D O I：

10.1016/S0020-2452(97)83532-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest, Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

引用

页码：247 / 257

页数：11

共 50 条

[21] PASSIVE IMMUNOTHERAPY IN THE TREATMENT OF ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
JACOBSON, JM
COLMAN, N
OSTROW, NA
SIMSON, RW
TOMESCH, D
MARLIN, L
RAO, M
MILLS, JL
CLEMENS, J
PRINCE, AM
[J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02) : 298 - 305
[22] FAILURE OF ADJUNCTIVE CYTOMEGALOVIRUS INTRAVENOUS IMMUNE GLOBULIN TO IMPROVE EFFICACY OF GANCICLOVIR IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME AND CYTOMEGALOVIRUS RETINITIS - A PHASE-1 STUDY
JACOBSON, MA
ODONNELL, JJ
ROUSELL, R
DIONIAN, B
MILLS, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (01) : 176 - 178
[23] KARPAS A, 1985, LANCET, V2, P695
[24] A controlled trial of intravenous immune globulin for the prevention of serious infections in adults with advanced human immunodeficiency virus infection
Kiehl, MG
Stoll, R
Broder, M
Mueller, C
Foerster, EC
Domschke, W
[J]. ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (22) : 2545 - 2550
[25] Summary of antibody workshop: The role of humoral immunity in the treatment and prevention of emerging and extant infectious diseases
Krause, RM
Dimmock, NJ
Morens, DM
[J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03): : 549 - 559
[26] Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns
Lambert, JS
Mofenson, LM
Fletcher, CV
Moye, J
Stiehm, ER
Meyer, WA
Nemo, GJ
Mathieson, BJ
Hirsch, G
Sapan, CV
Cummins, LM
Jimenez, E
ONeill, E
Kovacs, A
Stek, A
[J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (02) : 283 - 291
[27] LEVY J, 1994, BLOOD, V84, P2130
[28] Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization
McGory, RW
Ishitani, MB
Oliveira, WM
Stevenson, WC
McCullough, CS
Dickson, RC
Caldwell, SH
Pruett, TL
[J]. TRANSPLANTATION, 1996, 61 (09) : 1358 - 1364
[29] CONTROLLED TRIAL TO EVALUATE PROTECTION OF HIGH-RISK INFANTS AGAINST RESPIRATORY SYNCYTIAL VIRUS-DISEASE BY USING STANDARD INTRAVENOUS IMMUNE GLOBULIN
MEISSNER, HC
FULTON, DR
GROOTHUIS, JR
GEGGEL, RL
MARX, GR
HEMMING, VG
HOUGEN, T
SYNDMAN, DR
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) : 1655 - 1658
[30] PROPHYLACTIC INTRAVENOUS IMMUNOGLOBULIN IN HIV-INFECTED CHILDREN WITH CD4+ COUNTS OF 0.20X10(9)/L OR MORE - EFFECT ON VIRAL, OPPORTUNISTIC, AND BACTERIAL-INFECTIONS
MOFENSON, LM
MOYE, J
BETHEL, J
HIRSCHHORN, R
JORDAN, C
NUGENT, R
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (04): : 483 - 488

← 1 2 3 4 5 →